RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Adamas Pharmaceuticals Stock

Adamas Pharmaceuticals ROCE 2024

Adamas Pharmaceuticals ROCE

0

Ticker

ADMS

ISIN

US00548A1060

WKN

A111X7

In 2024, Adamas Pharmaceuticals's return on capital employed (ROCE) was 0, a 0% increase from the 0 ROCE in the previous year.

Adamas Pharmaceuticals Aktienanalyse

What does Adamas Pharmaceuticals do?

Adamas Pharmaceuticals, Inc. is an American biopharmaceutical company specializing in the development of therapies for neurological diseases. It was founded in 2000 by Gregory Went and Mark Gergen and is headquartered in Emeryville, California. The company's goal is to develop groundbreaking therapies that can improve the lives of people with neurological diseases, particularly focusing on the treatment of Parkinson's disease, multiple sclerosis, and epilepsy. Adamas Pharmaceuticals' business model is based on the discovery, development, and commercialization of novel drugs based on patient needs and scientific insights. The company collaborates closely with leading scientists, doctors, and patient organizations to maximize the effectiveness of its medications. Adamas Pharmaceuticals is divided into several business units, each specializing in different neurological diseases, including Parkinson's disease, multiple sclerosis, and epilepsy. The company has developed GOCOVRI, the first and only medication for the treatment of dyskinesias in Parkinson's disease patients. It is also working on medications for multiple sclerosis and epilepsy. Adamas Pharmaceuticals has partnerships with other pharmaceutical companies, including a collaboration with Biogen, a leading biotechnology company specializing in neurological disease therapies. The company is dedicated to making significant advancements in the fight against neurological diseases through its focus on patient needs and collaboration with scientists and doctors. Adamas Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Adamas Pharmaceuticals's Return on Capital Employed (ROCE)

Adamas Pharmaceuticals's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Adamas Pharmaceuticals's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Adamas Pharmaceuticals's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Adamas Pharmaceuticals’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Adamas Pharmaceuticals stock

What is the ROCE (Return on Capital Employed) of Adamas Pharmaceuticals this year?

The ROCE of Adamas Pharmaceuticals is 0 undefined this year.

How has the ROCE (Return on Capital Employed) of Adamas Pharmaceuticals developed compared to the previous year?

The ROCE of Adamas Pharmaceuticals has increased by 0% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Adamas Pharmaceuticals?

A high Return on Capital Employed (ROCE) indicates that Adamas Pharmaceuticals has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Adamas Pharmaceuticals?

A low ROCE (Return on Capital Employed) can indicate that Adamas Pharmaceuticals has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Adamas Pharmaceuticals impact the company?

An increase in the ROCE of Adamas Pharmaceuticals can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Adamas Pharmaceuticals affect the company?

A decrease in ROCE of Adamas Pharmaceuticals can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Adamas Pharmaceuticals?

Some factors that can affect Adamas Pharmaceuticals's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Adamas Pharmaceuticals so important for investors?

The ROCE of Adamas Pharmaceuticals is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Adamas Pharmaceuticals take to improve the ROCE?

To improve the ROCE, Adamas Pharmaceuticals can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Adamas Pharmaceuticals pay?

Over the past 12 months, Adamas Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Adamas Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Adamas Pharmaceuticals?

The current dividend yield of Adamas Pharmaceuticals is .

When does Adamas Pharmaceuticals pay dividends?

Adamas Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Adamas Pharmaceuticals?

Adamas Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Adamas Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Adamas Pharmaceuticals located?

Adamas Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Adamas Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Adamas Pharmaceuticals from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Adamas Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Adamas Pharmaceuticals in the year 2023?

In the year 2023, Adamas Pharmaceuticals distributed 0 USD as dividends.

In which currency does Adamas Pharmaceuticals pay out the dividend?

The dividends of Adamas Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Adamas Pharmaceuticals

Our stock analysis for Adamas Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Adamas Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.